Android app on Google Play

Catalyst Pharma (CPRX) Runs Higher on No New Information

August 24, 2012 9:17 AM EDT Send to a Friend
Catalyst Pharmaceutical Partners (Nasdaq: CPRX) is running higher early Friday following a Seeking Alpha blog post about Phase II trial results to be released in September for CPP-109.

Of note, CPP-109 timing was already announced with Catalysts' Q2 results release (under "Recent Accomplishments and Upcoming Events").

View the CPP-109 presentation here, which is on the company website.

At the bottom of the blog post, the author notes:

"Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Additional disclosure: Family member is long CPRX. Disclaimer: This article is intended for informational and entertainment use only, and should not be construed as professional investment advice. They are my opinions only. Trading stocks is risky -- always be sure to know and understand your risk tolerance. You can incur substantial financial losses in any trade or investment. Always do your own due diligence before buying and selling any stock, and/or consult with a licensed financial adviser."

Shares are up about 8.7 percent in early trading Friday.




You May Also Be Interested In


Related Categories

Insiders' Blog, Momentum Movers

Add Your Comment